Literature DB >> 19052538

The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy.

Christina M Wyatt1, Susan Morgello, Rebecca Katz-Malamed, Catherine Wei, Mary E Klotman, Paul E Klotman, Vivette D D'Agati.   

Abstract

With prolonged survival and aging of the HIV-infected population in the era of antiretroviral therapy, biopsy series have found a broad spectrum of HIV-related and co-morbid kidney disease in these patients. Our study describes the variety of renal pathology found in a prospective cohort of antiretroviral-experienced patients (the Manhattan HIV Brain Bank) who had consented to postmortem organ donation. Nearly one-third of 89 kidney tissue donors had chronic kidney disease, and evidence of some renal pathology was found in 75. The most common diagnoses were arterionephrosclerosis, HIV-associated nephropathy and glomerulonephritis. Other diagnoses included pyelonephritis, interstitial nephritis, diabetic nephropathy, fungal infection and amyloidosis. Excluding 2 instances of acute tubular necrosis, slightly over one-third of the cases would have been predicted using current diagnostic criteria for chronic kidney disease. Based on semi-quantitative analysis of stored specimens, pre-mortem microalbuminuria testing could have identified an additional 12 cases. Future studies are needed to evaluate the cost-effectiveness of more sensitive methods for defining chronic kidney disease, in order to identify HIV-infected patients with early kidney disease who may benefit from antiretroviral therapy and other interventions known to delay disease progression and prevent complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052538      PMCID: PMC2704860          DOI: 10.1038/ki.2008.604

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

2.  Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time.

Authors:  Susan Morgello; Rashid Mahboob; Tatiana Yakoushina; Shafat Khan; Karin Hague
Journal:  Arch Pathol Lab Med       Date:  2002-02       Impact factor: 5.534

3.  Predictors of proteinuria and renal failure among women with HIV infection.

Authors:  Lynda Anne Szczech; Stephen J Gange; Charles van der Horst; John A Bartlett; Mary Young; Mardge H Cohen; Kathryn Anastos; Preston S Klassen; Laura P Svetkey
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy.

Authors:  S Hailemariam; M Walder; H R Burger; G Cathomas; M Mihatsch; U Binswanger; P M Ambühl
Journal:  Swiss Med Wkly       Date:  2001-07-14       Impact factor: 2.193

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.

Authors:  Lynda Anne Szczech; Samir K Gupta; Ramez Habash; Antonio Guasch; Robert Kalayjian; Richard Appel; Timothy A Fields; Laura P Svetkey; Katherine H Flanagan; Paul E Klotman; Jonathan A Winston
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

8.  [Renal involvement in the human immunodeficiency virus infection].

Authors:  Vicente Giner; María José Esteban; Conrado Fernández; María José Galindo; María Rosa Oltra; Vicente Oliver; Juan Carlos Rodríguez; María José Forner; Federico Alcácer; José Guix; Josep Redón; Carlos Monteagudo
Journal:  Med Clin (Barc)       Date:  2004-05-01       Impact factor: 1.725

9.  Neuropsychiatric impact of hepatitis C on advanced HIV.

Authors:  E L Ryan; S Morgello; K Isaacs; M Naseer; P Gerits
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  52 in total

Review 1.  An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.

Authors:  Christine B Bruno; Jeffrey M Schapiro; Parya Saberi
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-04-25

2.  Glomerular MYH9 expression is reduced by HIV-1.

Authors:  Thomas Hays; Vivette D D'Agati; Jonathan A Garellek; Tjani Warren; Marc E Trubin; Deborah P Hyink; John Cijiang He; Paul E Klotman
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

3.  Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Michael G Shlipak; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael R Bennett; Chirag R Parikh; Joachim H Ix; Vasantha Jotwani
Journal:  Am J Nephrol       Date:  2019-09-25       Impact factor: 3.754

4.  HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2-driven CD4+ T-cell chemotactic response.

Authors:  Ping Chen; Zhengzi Yi; Weijia Zhang; Mary E Klotman; Benjamin K Chen
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

5.  Chronic Kidney Disease in the Aging Human Immunodeficiency Virus-Infected Population.

Authors:  Jeffrey B Kopp
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

6.  Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.

Authors:  Mohamad Zaidan; François-Xavier Lescure; Isabelle Brochériou; Sarah Dettwiler; Jean-Baptiste Guiard-Schmid; Jérôme Pacanowski; Eric Rondeau; Gilles Pialoux; Pierre-Marie Girard; Pierre Ronco; Emmanuelle Plaisier
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

Review 7.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

Review 8.  Controversies in the pathogenesis of HIV-associated renal diseases.

Authors:  Leslie A Bruggeman; Peter J Nelson
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

9.  Recurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantation.

Authors:  Sindhu Chandran; Kuang-Yu Jen; Zoltan G Laszik
Journal:  Am J Kidney Dis       Date:  2013-03-05       Impact factor: 8.860

10.  Urinary NGAL marks cystic disease in HIV-associated nephropathy.

Authors:  Neal Paragas; Thomas L Nickolas; Christina Wyatt; Catherine S Forster; Meghan Sise; Susan Morgello; Bernd Jagla; Charles Buchen; Peter Stella; Simone Sanna-Cherchi; Maria Luisa Carnevali; Silvia Mattei; Achiropita Bovino; Lucia Argentiero; Andrea Magnano; Prasad Devarajan; Kai M Schmidt-Ott; Landino Allegri; Paul Klotman; Vivette D'Agati; Ali G Gharavi; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.